Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Directorate change

Strengthens Board with appointment of Roy Davis as Non-Executive Director and Chair Designate

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology ("med tech") company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the appointment of Gordon Roy Davis ("Roy") as a Non-Executive Director and successor to Mark Abrahams. Mark has been Chair of the Board since June 2015 following the reverse acquisition of Inditherm plc by Inspiration Healthcare Ltd. Roy will become a Non-Executive Director with effect from 25 January 2024 and Chair from 21 March 2024, when Mark Abrahams will step down from the Board of the Company. On joining the Board, he will be appointed to the Nominations Committee and will succeed Mark Abrahams as Chair of this Committee.

Roy brings a wealth of commercial experience in medical devices companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. He has held leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualisation, until its acquisition by Olympus Corporation in 2008 for $1.9 billion.

He is currently Non-Executive Chair at LungLife AI plc, Foster and Freeman (the trading name of the Galton group of companies) and Rair Health Ltd and was until recently, Non-Executive Chair at Medica Group plc until its acquisition by IK Partners for £269 million earlier this year. 

Mark Abrahams, Chair of Inspiration Healthcare said: "I am delighted to welcome Roy to the Board. He has all the necessary credentials to guide the Company through its next phase of development and I look forward to working with him during the transition to becoming Chair."

Neil Campbell, Chief Executive Officer of Inspiration Healthcare said: "Roy's proven commercial track record, experience and understanding of the med tech sector will be incredibly important to the Company as we continue to deliver our strategy. His knowledge of growing companies on the public markets will add significant value and makes him an ideal successor to Mark Abrahams. We look forward to capitalising on his expertise in our space."

Roy Davis, Chair designate of Inspiration Healthcare said: "I am delighted to be joining the Board of Inspiration Healthcare. The Company is addressing a critical need, providing innovative, lifesaving neonatal technologies and has the right products and expertise to deliver significant long-term sustainable growth. I look forward to working with Neil, the Executive team and the rest of the Board in executing the strategy and delivering the next stage of the Company's development."

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Gordon Roy Davis (aged 67 years) holds/has held the following directorships/partnerships in the last five years:

In addition to the above, Roy Davis was a director of C-Quential Limited until his resignation on 28 February 2001. The company entered into a creditors voluntary liquidation on 11 February 2002 and was subsequently dissolved on 18 August 2007.

Gordon Roy Davis holds no ordinary shares in the Company.

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates from its world-class Manufacturing and Technology Centre in Croydon, South London and from its facility in Hailsham, East Sussex.

Further information on Inspiration Healthcare can be found at https://inspirationhealthcaregroup.com/.